Background <p>This study aimed to evaluate the efficacy of the intravenous fixed-dose combination (IV FDC) of acetaminophen and ibuprofen after total knee arthroplasty (TKA).</p> Methods <p>We retrospectively analyzed TKA patients, dividing them into control and IV FDC groups using 1:1 propensity matching based on age and sex. The primary outcome was the Visual Analog Scale (VAS) score at 8&#xa0;h, 16&#xa0;h, 24&#xa0;h, 48&#xa0;h, 72&#xa0;h, 96&#xa0;h, and 120&#xa0;h postoperatively. Secondary outcomes included opioid consumption, conversion to Morphine Milligram Equivalents (MME), and complications requiring additional consultations with other departments.</p> Results <p>A total of 70 patients were included in each group after propensity matching. The IV FDC group had significantly lower VAS scores at 96&#xa0;h (3.1 ± 0.7 vs. 3.5 ± 1.3, <i>p</i> = 0.033) and 120&#xa0;h (3.1 ± 0.8 vs. 3.7 ± 1.4, <i>p</i> = 0.003) compared to the control group. Opioid consumption was also significantly lower in the IV FDC group compared to the control group, both on POD 1 (51.9 ± 41.0 vs. 82.5 ± 64.3, <i>p</i> &lt; 0.001) and in total consumption (131.9 ± 92.5 vs. 175.2 ± 129.3, <i>p</i> = 0.025).</p> Conclusion <p>The use of an IV FDC of acetaminophen and ibuprofen after TKA significantly reduced opioid consumption and demonstrated a modest improvement in pain scores at later postoperative time points.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Efficacy of an intravenous acetaminophen/ibuprofen fixed-dose combination after total knee arthroplasty

  • Sumin Lim,
  • Tae Hun Kim,
  • Do Young Park,
  • Jung Sunwoo,
  • Jun Young Chung

摘要

Background

This study aimed to evaluate the efficacy of the intravenous fixed-dose combination (IV FDC) of acetaminophen and ibuprofen after total knee arthroplasty (TKA).

Methods

We retrospectively analyzed TKA patients, dividing them into control and IV FDC groups using 1:1 propensity matching based on age and sex. The primary outcome was the Visual Analog Scale (VAS) score at 8 h, 16 h, 24 h, 48 h, 72 h, 96 h, and 120 h postoperatively. Secondary outcomes included opioid consumption, conversion to Morphine Milligram Equivalents (MME), and complications requiring additional consultations with other departments.

Results

A total of 70 patients were included in each group after propensity matching. The IV FDC group had significantly lower VAS scores at 96 h (3.1 ± 0.7 vs. 3.5 ± 1.3, p = 0.033) and 120 h (3.1 ± 0.8 vs. 3.7 ± 1.4, p = 0.003) compared to the control group. Opioid consumption was also significantly lower in the IV FDC group compared to the control group, both on POD 1 (51.9 ± 41.0 vs. 82.5 ± 64.3, p < 0.001) and in total consumption (131.9 ± 92.5 vs. 175.2 ± 129.3, p = 0.025).

Conclusion

The use of an IV FDC of acetaminophen and ibuprofen after TKA significantly reduced opioid consumption and demonstrated a modest improvement in pain scores at later postoperative time points.